HemaSphere (Apr 2022)

P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 CASTOR TRIAL

  • P Sonneveld,
  • A Chanan-Khan,
  • K Weisel,
  • AK Nooka,
  • T Masszi,
  • M Beksac,
  • I Spicka,
  • V Hungria,
  • M Munder,
  • MV Mateos,
  • TM Mark,
  • MD Levin,
  • T Ahmadi,
  • X Qin,
  • W Garvin Mayo,
  • X Gai,
  • J Carey,
  • R Carson,
  • A Spencer

DOI
https://doi.org/10.1097/01.HS9.0000829588.31575.a9
Journal volume & issue
Vol. 6
pp. 12 – 12

Abstract

Read online

No abstracts available.